Magnetization transfer imaging in multiple sclerosis

Journal of Neuroimaging

Volumn 15, Issue 4 SUPPL., 2005, Pages

  Horsfield, Mark A ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Contrast; Macromolecule; Magnetic resonance imaging; Magnetization transfer imaging; Magnetization transfer ratio; Multiple sclerosis; Protons

Indexed keywords

GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MYELIN;

AUTOPSY; CELL LOSS; CELL ORGANELLE; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; DEMYELINATION; DISEASE COURSE; HUMAN; INFLAMMATION; MACROMOLECULE; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE DIAGNOSIS; REMYELINIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE INJURY;

BRAIN; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MULTIPLE SCLEROSIS;

EID: 29444437391     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1177/1051228405282242     Document Type: Review

References (79)

1. Damadian R. Tumor detection by nuclear magnetic resonance. Science 1971;171:1151-1153.
2. Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic-resonance [letter]. Nature 1973;242:190-191.
3. Bydder GM, Steiner RE, Young IR, et al. Clinical NMR imaging of the brain: 140 cases. AJR Am J Roentgenol 1982;139:215-236.
4. Rinck PA, Bielke G, Meves M. Modified spin-echo sequence in tumor diagnosis. In: Proceedings of the Society of Magnetic Resonance in Medicine. Second Annual Meeting, San Francisco 1983;300-301.
5. Also in Magn Reson Med 1984;1:236 (abstract).
6. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135-144.
7. Balaban RS, Ceckler TL. Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q 1992;8:116-137.
8. Edelman RR, Ahn SS, Chien D, et al. Improved time-of-flight MR angiography of the brain with magnetization transfer contrast. Radiology 1992;184:395-399.
9. Finelli DA, Hurst GC, Gullapali RP, Bellon EM. Improved contrast of enhancing brain lesions on postgadolinium T1-weighted spin-echo images with use of magnetization transfer. Radiology 1994;190:553-559.
10. Mehta RC, Pike GB, Enzmann DR. Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer. AJNR Am J Neuroradiol 1995;16:1771-1778.
11. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterisation with magnetization transfer imaging. Radiology 1992;182:483-491.
12. Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 2005;15(suppl 1):10S-21S.
13. Barker GJ, Schreiber W, Gass A, Ranjava JP, Campi A, van Waesberghe JHTM. Standardizing magnetisation transfer ratio measurements between MR scanners from different manufacturers. In: Proceedings of the 5th Annual Meeting of ISMRM, Vancouver; 1997:1556.
14. Grad J, Bryant RG. Nuclear magnetic cross-relaxation spectroscopy. J Magn Reson 1990;90:1-8.
15. Davies GR, Ramani A, Dalton CM, et al. Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? Mult Scler 2003;9:246-249.
16. Fazekas F, Ropele S, Enzinger C, Seifert T, Strasser-Fuchs S. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 2002;8:479-484.
17. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
18. Barker GJ, Schreiber W, Gass A, Ranjava JP, Campi A, van Waesberghe JH. Standardising magnetisation transfer ratio measurements between MR scanners from different manufacturers. Proc Intl Soc Magn Reson Med 1997;5:1556.
19. Sormani MP, Iannucci G, Rocca MA. Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers. AJNR Am J Neuroradiol 2000;21:133-136.
20. Bakshi R, Dandamudi VSR, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging 2005;15(suppl 1):30S-45S.
21. Kalkers NF, Hintzen RQ, van Waesberghe JH, et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 2001;184:155-162.
22. Horsfield MA, Rovaris M, Rocca MA, et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003;216:169-177.
23. Ge YL, Grossman RI, Udupa JK, Babb JS, Mannon LJ, McGowan JC. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assut Tomogr 2002;26:62-68.
24. Silver NC, Barker GJ, MacManus DG, Tofts PS, Miller DH. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. J Neurol Neurosurg Psychiatry 1997;62:223-228.
25. Mehta RC, Pike GB, Enzmann DR. Magnetization transfer MR of the normal adult brain. AJNR Am J Neuroradiol 1995;16:2085-2091.
26. Rovaris M, Iannucci G, Cercignani M, et al. Age-related changes of conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology 2003;227:731-738.
27. Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL. Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2002;23:1334-1341.
28. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225-231.
29. Deloire-Grassin MS, Brochet B, Quesson B, et al. In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci 2000;178:10-16.
30. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 2003;50:309-314.
31. Cook LL, Foster PJ, Mitchell JR, Karlik SJ. In vivo 4.O-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis. J Magn Reson Imaging 2004;20:563-571.
32. van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754.
33. Mottershead JP, Schmierer K, Clemence M, et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis-a post-mortem study of the spinal cord. J Neurol 2003;250:1293-1301.
34. Bot JC, Blezer EL, Kamphorst W, et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004;233:531-540.
35. Dousset V, Armand JP, Lacoste D, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol 1997;18:895-901.
36. Silver NC, Barker GJ, MacManus DG, Miller DH, Thorpe JW, Howard RS. Decreased magnetisation transfer ratio due to demyelination: a case of central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1996;61:208-209.
37. Inglese M, Rovaris M, Bianchi S, et al. Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001;70:444-449.
38. Inglese M, Ghezzi A, Bianchi S, et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002;59:250-255.
39. Thorpe JW, Barker GJ, Jones SJ, et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995;59:487-492.
40. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67.
41. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683.
42. Hiehle JF Jr, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77.
43. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482.
44. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR imaging in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515.
45. Filippi M, Rocca MA, Minicucci L, et al. Magnetization transfer imaging of patients with definite MS and negative conventional MRI. Neurology 1999;52:845-848.
46. Ge Y, Grossman RI, Babb JS, He J, Mannon LJ. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2003;24:1935-1940.
47. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RH. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Imaging 1994;12:33-42.
48. Filippi M, Tortorella C, Rovaris M. Magnetic resonance imaging of multiple sclerosis. J Neuroimaging 2002;12:289-301.
49. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617.
50. Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157-161.
51. Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal appearing brain tissue in MS. Neurology 2000;54:186-193.
52. Richert ND, Ostuni JL, Bash CN, Duyn JH, McFarland HF, Frank JA. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. AJNR Am J Neuroradiol 1998;19:1705-1713.
53. Davies GR, Ramio-Torrenta L, Hadjiprocopis A, et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:998-1002.
54. Rovaris M, Agosta F, Sormani MP, et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003;126:2323-2332.
55. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608.
56. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21:402-408.
57. Lee KY, Kim TK, Park M, Ko S, Song IC, Cho IH. Age-related changes in conventional and magnetization transfer MR imaging in elderly people: comparison with neurocognitive performance. Korean J Radiol 2004;5:96-101.
58. Van Der Flier WM, Van Den Heuvel DM, Weverling-Rijnsburger AW, et al. Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002;59:874-879.
59. Ragin AB, Storey P, Cohen BA, Edelman RR, Epstein LG. Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 2004;63:2293-2297.
60. Audoin B, Au Duong MV, Ranjeva JP, et al. Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp 2005;24:216-228.
61. Jordan EK, McFarland HI, Lewis BK, et al. Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset. AJNR Am J Neuroradiol 1999;20:965-976.
62. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814.
63. Goodkin DE, Rooney WD, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-1697.
64. Silver NC, Lai M, Symms MR, Barker GJ, McDonald WI, Miller DH. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998;51:758-764.
65. Pike GB, De Stefano N, Narayanan S, et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 2000;215:824-830.
66. Hickman SJ, Toosy AT, Jones SJ, et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 2004;127:692-700.
67. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003;60:1073-1081.
68. Tench CR, Morgan PS, Jaspan T, Auer DP, Constantinescu CS. Spinal cord imaging in multiple sclerosis. J Neuroimaging 2005;15(suppl 1):94S-102S.
69. Bozzali M, Rocca MA, Iannucci G, Pereira C, Comi G, Filippi M. Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis. AJNR Am J Neuroradiol 1999;20:1803-1808.
70. Nijeholt GJ, Castelijns JA, Lazeron RH, et al. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J Neuroimaging 2000;10:67-72.
71. Filippi M, Bozzali M, Horsfield MA, et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 2000;54:207-213.
72. Filippi M, Inglese M, Rovaris M, et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000;55:940-946.
73. Richert ND, Ostuni JL, Bash CN, Leist TP, McFarland HF, Frank JA. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001;7:49-58.
74. Kita M, Goodkin DE, Bacchetti P, Waubant E, Nelson SJ, Majumdar S. Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a. Neurology 2000;54:1741-1745.
75. Richert N, Bagnato F, Howard T, et al. Whole brain magnetization transfer analysis of relapsing-remitting multiple sclerosis patients treated with IFNB-1b or glatiramer acetate. Mult Scler 2003;9(suppl 1):S64. Abstract P273.
76. Inglese M, van Waesberghe JH, Rovaris M, et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003;60:853-860.
77. Filippi M, Rocca MA, Pagani E, et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch Neurol 2004;61:1409-1412.
78. Lin X, Turner B, Constantinescu C, et al. Cerebral volume change in secondary progressive multiple sclerosis: effect of intravenous immunoglobulins (IVIG) [abstract]. J Neurol 2002;249(suppl 1):I/169.
79. Horsfield MA, Barker GJ, Barkhof F, Miller DH, Thompson AJ, Filippi M. Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Reson Imaging 2003;17:389-397.